Enzymotec Shares Plummet on Profit Drop

The company cited a drop in sales of premium Omega-3 products in the United States and Australia.

comments Print
Enzymotec saw its shares plunge in New York yesterday after it reported a sharp drop in sales and profits for the second quarter and said it saw no rapid recovery ahead.